A randomized, double-blind, placebo-controlled study of the efficacy, safety, and tolerability of adjunctive carisbamate treatment in patients with partial-onset seizures.

• To assess the efficacy, safety, and tolerability of adjunctive carisbamate treatment at 800 mg/day and 1,200 mg/day in patients with partial-onset seizures (POS).

Nyckelord

Adult

Anticonvulsants

administration & dosage

adverse effects

Carbamates

administration & dosage

adverse effects

Double-Blind Method

Drug Administration Schedule

Drug Therapy

Combination

methods

Epilepsies

Partial

diagnosis

drug therapy

Female

Humans

Male

Middle Aged

Outcome Assessment (Health Care)

methods

Publikations- och innehållstyp

ref (ämneskategori)

art (ämneskategori)